SRD5A3 and hepatocellular carcinoma: In the current study, SRD5A3 expression in different cancers including HCC was analyzed by bioinformatics, and further verified with clinical specimens of HCC tumor (HCC) and corresponding adjacent non-HCC liver (peri-HCC).